نتایج جستجو برای: familial mds

تعداد نتایج: 63422  

Journal: :Blood 2002
Lars Nilsson Ingbritt Astrand-Grundström Kristina Anderson Ingrid Arvidsson Peter Hokland David Bryder Lars Kjeldsen Bertil Johansson Eva Hellström-Lindberg Robert Hast Sten Eirik W Jacobsen

Clonality studies of mature cells suggest that the primary transformation event in myelodysplastic syndrome (MDS) most frequently occurs in a myeloid-restricted progenitor, a hypothesis supported by recent studies of purified CD34(+)Thy1(+) hematopoietic stem cells (HSCs) in cases with trisomy 8 (+8). In contrast, we recently demonstrated that a lymphomyeloid HSC is the target for transformatio...

2017
Karine Z. Oben Sara S. Alhakeem Mary K. McKenna Jason A. Brandon Rajeswaran Mani Sunil K. Noothi Liu Jinpeng Shailaja Akunuru Sanjit K. Dhar Inder P. Singh Ying Liang Chi Wang Ahmed Abdel-Latif Harold F. Stills Jr Daret K. St. Clair Hartmut Geiger Natarajan Muthusamy Kaoru Tohyama Ramesh C. Gupta Subbarao Bondada

Myelodysplastic syndromes (MDS) are a diverse group of malignant clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, dysplastic cell morphology in one or more hematopoietic lineages, and a risk of progression to acute myeloid leukemia (AML). Approximately 50% of MDS patients respond to current FDA-approved drug therapies but a majority of responders relapse with...

Journal: :Blood 2002
Yogen Saunthararajah Ryotaro Nakamura Jun-Mo Nam Jamie Robyn Fausto Loberiza Jaroslaw P Maciejewski Toni Simonis Jeffrey Molldrem Neal S Young A John Barrett

The extent and importance of autoimmune mechanisms in myelodysplastic syndrome (MDS) and the role of immunosuppression in the treatment of this disease are not well defined. We report overrepresentation of HLA-DR2 and its serologic split HLA-DR15 in both MDS and aplastic anemia (AA). Four clinically and ethnically defined patient groups were analyzed. The HLA-DR15 antigen frequencies among Nort...

2015
Abdallah Abou Zahr Ehab Saad Aldin Rami S Komrokji Amer M Zeidan

Myelodysplastic syndromes (MDS) represent a heterogeneous group of acquired clonal hematopoietic disorders characterized by peripheral blood cytopenias, paradoxical BM hypercellularity, ineffective hematopoiesis, and increased risk of leukemic transformation. Risk stratification, using different prognostic scores and markers, is at the core of MDS management. Deletion 5q [del(5q)] MDS is a dist...

2016
Lisa Pleyer Sonja Burgstaller Reinhard Stauder Michael Girschikofsky Heinz Sill Konstantin Schlick Josef Thaler Britta Halter Sigrid Machherndl-Spandl Armin Zebisch Angelika Pichler Michael Pfeilstöcker Eva-Maria Autzinger Alois Lang Klaus Geissler Daniela Voskova Dietmar Geissler Wolfgang R. Sperr Sabine Hojas Inga M. Rogulj Johannes Andel Richard Greil

BACKGROUND The MDS-IWG and NCCN currently endorse both FAB and WHO classifications of MDS and AML, thus allowing patients with 20-30 % bone marrow blasts (AML20-30, formerly MDS-RAEB-t) to be categorised and treated as either MDS or AML. In addition, an artificial distinction between AML20-30 and AML30+ was made by regulatory agencies by initially restricting approval of azacitidine to AML20-30...

2014
Levi J. Beverly Daniel T. Starczynowski

Myelodysplastic syndromes (MDS) are a collection of hematopoietic stem cell (HSC) disorders that consist of blood cytopenias, marrow dysplasia, and a predisposition to acute myeloid leukemia (AML). Approximately 30% of MDS patients go on to develop aggressive AML. MDS is fatal in a majority of patients as a result of marrow failure, immune dysfunction, and/or transformation to overt leukemia. A...

2011
Vincent Mor Orna Intrator Mark Aaron Unruh Shubing Cai

BACKGROUND The Minimum Data Set (MDS) for nursing home resident assessment has been required in all U.S. nursing homes since 1990 and has been universally computerized since 1998. Initially intended to structure clinical care planning, uses of the MDS expanded to include policy applications such as case-mix reimbursement, quality monitoring and research. The purpose of this paper is to summariz...

Journal: :CoRR 2015
Chin Hei Chan Maosheng Xiong

Maximum-distance separable (MDS) convolutional codes form an optimal family of convolutional codes, the study of which is of great importance. There are very few general algebraic constructions of MDS convolutional codes. In this paper, we construct a large family of unit-memory MDS convolutional codes over Fq with flexible parameters. Compared with previous works, the field size q required to ...

Journal: :Anticancer research 2012
Takahiro Yamauchi Yasufumi Matsuda Mihoko Takai Toshiki Tasaki Naoko Hosono Eiju Negoro Satoshi Ikegaya Kazutaka Takagi Shinji Kishi Akira Yoshida Yoshimasa Urasaki Takanori Ueda

BACKGROUND/AIM Pancytopenia is caused by acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), aplastic anemia (AA), or by non-hematological diseases. Because Wilms' tumor-1 (WT1) is overexpressed in patients with AML and MDS, its expression level may be helpful for diagnosing these hematological malignancies. PATIENTS AND METHODS We retrospectively investigated the WT1 transcripts in...

2013
George I. Mias Rui Chen Yan Zhang Kunju Sridhar Donald Sharon Li Xiao Hogune Im Michael P. Snyder Peter L. Greenberg

Increased autoantibody reactivity in plasma from Myelodysplastic Syndromes (MDS) patients may provide novel disease signatures, and possible early detection. In a two-stage study we investigated Immunoglobulin G reactivity in plasma from MDS, Acute Myeloid Leukemia post MDS patients, and a healthy cohort. In exploratory Stage I we utilized high-throughput protein arrays to identify 35 high-inte...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید